Covered recipient · General Payments record
JAKE LESTER SEMON
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2022–2024
$1,946.70
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $597.43 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Stryker Corporation | $156.82 | 3 |
| Paragon 28, Inc. | $140.25 | 1 |
| Averitas Pharma Inc. | $90.01 | 2 |
| ConvaTec Inc. | $50.89 | 1 |
| TriCoast Surgical Solutions LLC | $40.46 | 1 |
| ABBVIE INC. | $22.67 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $22.01 | 1 |
| Next Science LLC | $21.92 | 1 |
| Smith & Nephew, Inc. | $21.08 | 1 |
| Bioventus LLC | $17.34 | 1 |
| Advanced Oxygen Therapy Inc. | $13.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.67 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106055620 | CMS |
| Advanced Oxygen Therapy Inc. | $13.98 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101075504 | CMS |
| Averitas Pharma Inc. | $37.80 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133445567 | CMS |
| Averitas Pharma Inc. | $52.21 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133445571 | CMS |
| Bioventus LLC | $17.34 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137449127 | CMS |
| ConvaTec Inc. | $50.89 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384594 | CMS |
| Next Science LLC | $21.92 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147393150 | CMS |
| Paragon 28, Inc. | $140.25 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138435684 | CMS |
| Smith+Nephew, Inc. | $21.08 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149568225 | CMS |
| Stryker Corporation | $132.08 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119975353 | CMS |
| Stryker Corporation | $11.81 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119975355 | CMS |
| Stryker Corporation | $12.93 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119975357 | CMS |
| Tricoast Surgical Solutions LLC | $40.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142064511 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $22.01 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105922629 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.